Cannabigerol modulates α2-adrenoceptor and 5-HT1A receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat
暂无分享,去创建一个
[1] A. Pérez-Samartín,et al. Functional characterization of cannabidiol effect on the serotonergic neurons of the dorsal raphe nucleus in rat brain slices , 2022, Frontiers in Pharmacology.
[2] Wendong Huang,et al. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD) , 2022, Basic & clinical pharmacology & toxicology.
[3] H. Ishiguro,et al. New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders , 2022, International journal of molecular sciences.
[4] C. Soriano-Mas,et al. The Role of the Locus Coeruleus in Pain and Associated Stress-Related Disorders , 2021, Biological Psychiatry.
[5] N. Assareh,et al. The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice. , 2021, Cannabis and Cannabinoid Research.
[6] R. Freire,et al. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options , 2021, Focus.
[7] M. Casarejos,et al. Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice , 2020, Molecular and Cellular Neuroscience.
[8] K. Vrana,et al. The Pharmacological Case for Cannabigerol , 2020, The Journal of Pharmacology and Experimental Therapeutics.
[9] C. Stevenson,et al. In it together? The case for endocannabinoid–noradrenergic interactions in fear extinction , 2021, The European journal of neuroscience.
[10] Z. Xi,et al. Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals , 2020, International journal of molecular sciences.
[11] R. Freire,et al. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options , 2020, Frontiers in Psychiatry.
[12] R. Laprairie,et al. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa , 2020, Scientific Reports.
[13] E. Mazzon,et al. Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease , 2020, Molecules.
[14] M. Reyes-Parada,et al. A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT1A Receptors , 2020, Neurotoxicity research.
[15] R. Arslan,et al. The anxiolytic effect of perampanel and possible mechanisms mediating its anxiolytic effect in mice. , 2020, Life sciences.
[16] D. Charney,et al. The role of the locus coeruleus in the generation of pathological anxiety , 2020, Brain and neuroscience advances.
[17] A. Cataldi,et al. Neuroprotective and Neuromodulatory Effects Induced by Cannabidiol and Cannabigerol in Rat Hypo-E22 cells and Isolated Hypothalamus , 2020, Antioxidants.
[18] P. Albert,et al. The 5-HT1A receptor: Signaling to behavior. , 2019, Biochimie.
[19] R. McLaughlin,et al. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain , 2018, Pain.
[20] F. Guimarães,et al. Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[21] R. Franco,et al. Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes , 2018, Front. Pharmacol..
[22] J. Pineda,et al. Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid‐induced effects , 2018, Life sciences.
[23] J. Pineda,et al. Characterization of functional μ opioid receptor turnover in rat locus coeruleus: an electrophysiological and immunocytochemical study , 2017, British journal of pharmacology.
[24] Benjamin J. Whalley,et al. Molecular Pharmacology of Phytocannabinoids. , 2017, Progress in the chemistry of organic natural products.
[25] M. Morgan,et al. Relative contribution of the dorsal raphe nucleus and ventrolateral periaqueductal gray to morphine antinociception and tolerance in the rat , 2016, The European journal of neuroscience.
[26] Benjamin J. Whalley,et al. Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats , 2016, Psychopharmacology.
[27] Jean-Claude Béïque,et al. Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids , 2016, Proceedings of the National Academy of Sciences.
[28] F. Guimarães,et al. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors , 2016, Behavioural Brain Research.
[29] F. Pilar-Cuéllar,et al. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors , 2016, Neuropharmacology.
[30] C. P. Ford,et al. Mechanisms of 5‐HT1A receptor‐mediated transmission in dorsal raphe serotonin neurons , 2016, The Journal of physiology.
[31] F. Guimarães,et al. Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences , 2015, Behavioural Brain Research.
[32] M. Bellido,et al. A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis , 2014, PloS one.
[33] M. Bellido,et al. Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice , 2014, Neurotherapeutics.
[34] H. Cohen,et al. Animal Models of Post‐Traumatic Stress Disorder , 2013, Current protocols in neuroscience.
[35] K. Antoniou,et al. The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently. , 2013, The international journal of neuropsychopharmacology.
[36] C. Limebeer,et al. Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability , 2013, Pharmacology Biochemistry and Behavior.
[37] G. Gobbi,et al. Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[38] Benjamin J. Whalley,et al. Cannabinol and cannabidiol exert opposing effects on rat feeding patterns , 2012, Psychopharmacology.
[39] P. Fletcher,et al. Cannabidiol, a non‐psychotropic component of cannabis, attenuates vomiting and nausea‐like behaviour via indirect agonism of 5‐HT1A somatodendritic autoreceptors in the dorsal raphe nucleus , 2012, British journal of pharmacology.
[40] L. Hunyady,et al. Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB1 receptor antagonists , 2012, Journal of Neural Transmission.
[41] B. Platt,et al. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour , 2012, Psychopharmacology.
[42] A. Dunn,et al. Participation of brainstem monoaminergic nuclei in behavioral depression , 2011, Pharmacology Biochemistry and Behavior.
[43] N. Coimbra,et al. Paradoxical effect of noradrenaline-mediated neurotransmission in the antinociceptive phenomenon that accompanies tonic–clonic seizures: Role of locus coeruleus neurons and α2- and β-noradrenergic receptors , 2011, Epilepsy & Behavior.
[44] J. Neumaier,et al. Regulation of dorsal raphe nucleus function by serotonin autoreceptors: A behavioral perspective , 2011, Journal of Chemical Neuroanatomy.
[45] J. Manzanares,et al. Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice , 2011, Journal of psychopharmacology.
[46] C. Limebeer,et al. Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews , 2011, Psychopharmacology.
[47] J. Monti. The structure of the dorsal raphe nucleus and its relevance to the regulation of sleep and wakefulness. , 2010, Sleep medicine reviews.
[48] Abigail M Polter,et al. 5-HT1A receptor-regulated signal transduction pathways in brain. , 2010, Cellular signalling.
[49] Y. Kayama,et al. Locus coeruleus neuronal activity during the sleep-waking cycle in mice , 2010, Neuroscience.
[50] Benjamin J. Whalley,et al. Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo , 2010, Journal of Pharmacology and Experimental Therapeutics.
[51] R. Pertwee,et al. Evidence that the plant cannabinoid cannabigerol is a highly potent α2‐adrenoceptor agonist and moderately potent 5HT1A receptor antagonist , 2010, British journal of pharmacology.
[52] C. Biojone,et al. Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT1A receptors , 2010, British journal of pharmacology.
[53] J. Pineda,et al. Effect of the CB1 receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices , 2009, British journal of pharmacology.
[54] F. Guimarães,et al. 5‐HT1A receptors are involved in the cannabidiol‐induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats , 2009, British journal of pharmacology.
[55] J. Kelly,et al. Comparison of the behavioural pharmacology of the Lister-Hooded with 2 commonly utilised albino rat strains , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[56] Anantha Shekhar,et al. Serotonergic Systems, Anxiety, and Affective Disorder , 2008, Annals of the New York Academy of Sciences.
[57] Christoph Schmitz,et al. The dorsal raphe nucleus—From silver stainings to a role in depression , 2007, Brain Research Reviews.
[58] A. Walf,et al. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents , 2007, Nature Protocols.
[59] Xiaohong Ma,et al. Selective 5‐HT1B receptor inhibition of glutamatergic and GABAergic synaptic activity in the rat dorsal and median raphe , 2006, The European journal of neuroscience.
[60] M. Pistis,et al. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons , 2006, The European journal of neuroscience.
[61] T. Cassano,et al. Correction for Gobbi et al., Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[62] J. Pineda,et al. α2-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons , 2005 .
[63] J. Pineda,et al. Cannabinoids enhance N-methyl-d-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices , 2004, Neuroscience Letters.
[64] J. Kew,et al. GABAergic modulation of 5-HT7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus , 2004, Neuropharmacology.
[65] J. Bockaert,et al. Differential coupling of 5-HT1A receptors occupied by 5-HT or 8-OH-DPAT to adenylyl cyclase , 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.
[66] P. L. Broadhurst,et al. Hyponeophagia and arousal in rats: Effects of diazepam, 5-methoxy-N,N-dimethyltryptamine, d-amphetamine and food deprivation , 2004, Psychopharmacology.
[67] T. Kirkham,et al. Observational analysis of feeding induced by Δ9-THC and anandamide , 2002, Physiology & Behavior.
[68] P. Celada,et al. The role of 5‐HT1B receptors in the regulation of serotonin cell firing and release in the rat brain , 2001, Journal of neurochemistry.
[69] J. Williams,et al. Regulation of central synaptic transmission by 5-HT(1B) auto- and heteroreceptors. , 2000, Molecular pharmacology.
[70] Jonathan D. Cohen,et al. Role of locus coeruleus in attention and behavioral flexibility , 1999, Biological Psychiatry.
[71] L. Lanfumey,et al. Antagonist properties of (−)‐pindolol and WAY 100635 at somatodendritic and postsynaptic 5‐HT1A receptors in the rat brain , 1998, British journal of pharmacology.
[72] G. Perrault,et al. Risk Assessment Behaviour: Evaluation of Utility in the Study of 5-HT-Related Drugs in the Rat Elevated Plus-Maze Test , 1997, Pharmacology Biochemistry and Behavior.
[73] K. Starke,et al. Subtype determination of soma-dendritic α2-autoreceptors in slices of rat locus coeruleus , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.
[74] Trevor Sharp,et al. Intracellular recordings from burst-firing presumed serotonergic neurones in the rat dorsal raphe nucleus in vivo , 1996, Brain Research.
[75] T. Chiu,et al. Action of dexmedetomidine on rat locus coeruleus neurones: intracellular recording in vitro. , 1995, European journal of pharmacology.
[76] F. Graeff,et al. Ethopharmacological analysis of rat behavior on the elevated plus-maze , 1994, Pharmacology Biochemistry and Behavior.
[77] S. Haj-Dahmane,et al. K+ channel and 5-hydroxytryptamine1A autoreceptor interactions in the rat dorsal raphe nucleus: Anin vitro electrophysiological study , 1991, Neuroscience.
[78] G. Aghajanian,et al. Common α2- and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices , 1987, Neuropharmacology.
[79] G. Aghajanian,et al. Hyperpolarization of serotonergic neurons by serotonin and LSD: Studies in brain slices showing increased K+ conductance , 1984, Brain Research.
[80] G. Aghajanian,et al. Locus coeruleus activity in vitro: intrinsic regulation by a calcium- dependent potassium conductance but not alpha 2-adrenoceptors , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.